Perspectives

This session highlighted the challenges and opportunities in the current oncology landscape, focusing on the pressures faced by platform and early-stage companies, the cyclical nature of oncology advancements, and the balance between market size and innovation.

Our latest "How To" guide focuses on developing an early cost-effectiveness model and how it can support the value demonstration strategy of a medicinal product by providing insights into its position in the treatment landscape, key value drivers, and potential evidence gaps.

Sharing insights and key takeaways on cell and gene therapies from the Asembia AXS25 Summit in Las Vegas.

Lumanity offers extensive experience-based strategic guidance and insights in the field of neuroscience. Our goal is to provide our clients with actionable solutions that de-risk and optimize the development and commercialization of therapies, ultimately improving the lives of patients who are impacted across a range of conditions.